NET PROFIT (x1000 SEK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
898
|
-6,588
|
-9,138 |
| Total assets |
53,996
|
47,050
|
44,384 |
| Current assets |
28,428
|
26,144
|
24,132 |
| Current liabilities |
45,957
|
39,418
|
37,789 |
| Equity capital |
3,207
|
2,233
|
2,245 |
| - share capital |
4,619
|
4,466
|
4,489 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.9%
|
4.7%
|
5.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
61.9%
|
66.3%
|
63.9% |
| Return on equity (ROE) |
28.0%
|
-295.0%
|
-407.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.